Ocular Therapeutix (OCUL) Earnings Date & Reports

A.I. Advisor
published Earnings

OCUL is expected to report earnings to fall 57.65% to -20 cents per share on August 05

Ocular Therapeutix OCUL Stock Earnings Reports
Q2'24
Est.
$-0.21
Q1'24
Missed
by $0.31
Q4'23
Missed
by $0.05
Q3'23
Beat
by $0.04
Q2'23
Beat
by $0.04
The last earnings report on May 07 showed earnings per share of -49 cents, missing the estimate of -18 cents. With 2.09M shares outstanding, the current market capitalization sits at 1.24B.
View a ticker or compare two or three
OCUL
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
15 Crosby Drive
Phone
+1 781 357-4000
Employees
267
Web
https://www.ocutx.com